HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Workineh Torben Selected Research

Workineh Torben Research Topics

Disease

12Schistosomiasis (Bilharziasis)
01/2020 - 05/2009
11Infections
01/2022 - 02/2007
5Schistosomiasis mansoni
01/2018 - 02/2007
3Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 05/2008
3Inflammation (Inflammations)
01/2019 - 01/2015
2Granuloma
02/2020 - 06/2018
2Parasitic Diseases (Parasitic Disease)
06/2014 - 05/2009
2Schistosomiasis haematobia (Schistosomiasis haematobium)
06/2014 - 03/2014
1Neglected Diseases
01/2020
1Fibrosis (Cirrhosis)
01/2019
1Reinfection
06/2018
1Chronic Disease (Chronic Diseases)
01/2018
1Viremia
10/2015
1Disease Progression
10/2015
1Colitis
01/2015
1Persistent Infection
06/2014
1Hypersensitivity (Allergy)
11/2011
1Communicable Diseases (Infectious Diseases)
04/2010
1Opportunistic Infections (Opportunistic Infection)
05/2008
1Immune Reconstitution Inflammatory Syndrome
05/2008

Drug/Important Bio-Agent (IBA)

14VaccinesIBA
01/2020 - 05/2009
4MicroRNAs (MicroRNA)IBA
01/2019 - 08/2014
3Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2014
3RNA (Ribonucleic Acid)IBA
02/2020 - 10/2015
3CannabinoidsIBA
01/2019 - 01/2015
3CalpainIBA
12/2018 - 06/2014
2Dronabinol (THC)FDA LinkGeneric
01/2019 - 01/2015
2AntigensIBA
06/2014 - 04/2010
2DNA (Deoxyribonucleic Acid)IBA
03/2014 - 09/2010
2Recombinant ProteinsIBA
09/2010 - 11/2009
1Amino AcidsFDA Link
01/2022
1CollagenIBA
01/2019
1beta-DefensinsIBA
01/2019
1Praziquantel (Biltricide)FDA Link
01/2018
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2016
1Antiviral Agents (Antivirals)IBA
10/2015
1Immunoglobulin G (IgG)IBA
11/2011
1Immunoglobulin E (IgE)IBA
11/2011
1AntibodiesIBA
03/2011
1resiquimodIBA
09/2010
1DNA VaccinesIBA
04/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2007
1CytokinesIBA
02/2007
1Interleukin-10 (Interleukin 10)IBA
02/2007
1Interleukin-12 (IL 12)IBA
02/2007
1Interleukin-4 (Interleukin 4)IBA
02/2007

Therapy/Procedure

2Therapeutics
01/2020 - 01/2018
1Mass Drug Administration
06/2018
1Highly Active Antiretroviral Therapy (HAART)
05/2008